img

Global and United States Organoid Biobank Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Organoid Biobank Market Report & Forecast 2024-2034

Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
Market Analysis and InsightsGlobal and United States Organoid Biobank Market
This report focuses on global and United States Organoid Biobank market, also covers the segmentation data of other regions in regional level and county level.
The global Organoid Biobank revenue was US$ 121 million in 2022 and is forecast to a readjusted size of US$ 390.4 million by 2033 with a CAGR of 18.5% during the review period (2023-2033).
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Global Organoid Biobank Scope and Market Size
Organoid Biobank market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Organoid Biobank market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Organoid Biobank market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids

Segment by Application


Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Organoid Biobank definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Organoid Biobank companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Organoid Biobank in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organoid Biobank revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Organoid Biobank Product Introduction
1.2 Global Organoid Biobank Outlook 2018 VS 2022 VS 2033
1.2.1 Global Organoid Biobank Market Size for the Year 2018-2033
1.2.2 United States Organoid Biobank Market Size for the Year 2018-2033
1.3 Organoid Biobank Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Organoid Biobank in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Organoid Biobank Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Organoid Biobank Market Dynamics
1.4.1 Organoid Biobank Industry Trends
1.4.2 Organoid Biobank Market Drivers
1.4.3 Organoid Biobank Market Challenges
1.4.4 Organoid Biobank Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Organoid Biobank by Type
2.1 Organoid Biobank Market Segment by Type
2.1.1 Tissue Derived Organoids
2.1.2 Pluripotent Stem Cell-derived Organoids
2.2 Global Organoid Biobank Market Size by Type (2018, 2022 & 2033)
2.3 Global Organoid Biobank Market Size by Type (2018-2033)
2.4 United States Organoid Biobank Market Size by Type (2018, 2022 & 2033)
2.5 United States Organoid Biobank Market Size by Type (2018-2033)
3 Organoid Biobank by Application
3.1 Organoid Biobank Market Segment by Application
3.1.1 Biopharmaceutical Companies
3.1.2 Contract Research Organizations
3.1.3 Academics and Research Institutes
3.2 Global Organoid Biobank Market Size by Application (2018, 2022 & 2033)
3.3 Global Organoid Biobank Market Size by Application (2018-2033)
3.4 United States Organoid Biobank Market Size by Application (2018, 2022 & 2033)
3.5 United States Organoid Biobank Market Size by Application (2018-2033)
4 Global Organoid Biobank Competitor Landscape by Company
4.1 Global Organoid Biobank Market Size by Company
4.1.1 Global Key Companies of Organoid Biobank, Ranked by Revenue (2022)
4.1.2 Global Organoid Biobank Revenue by Player (2018-2023)
4.2 Global Organoid Biobank Concentration Ratio (CR)
4.2.1 Organoid Biobank Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Organoid Biobank in 2022
4.2.3 Global Organoid Biobank Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Organoid Biobank Head office and Area Served
4.4 Global Key Players of Organoid Biobank, Product and Application
4.5 Global Key Players of Organoid Biobank, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Organoid Biobank Market Size by Company
4.7.1 Key Players of Organoid Biobank in United States, Ranked by Revenue (2022)
4.7.2 United States Organoid Biobank Revenue by Players (2021, 2022 & 2023)
5 Global Organoid Biobank Market Size by Region
5.1 Global Organoid Biobank Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Organoid Biobank Market Size by Region (2018-2033)
5.2.1 Global Organoid Biobank Market Size by Region: 2018-2023
5.2.2 Global Organoid Biobank Market Size by Region (2024-2033)
6 Americas
6.1 Americas Organoid Biobank Market Size YoY Growth 2018-2033
6.2 Americas Organoid Biobank Market Size by Type
6.2.1 Americas Organoid Biobank Market Size by Type (2018-2023)
6.2.2 Americas Organoid Biobank Market Size by Type (2024-2033)
6.2.3 Americas Organoid Biobank Market Share by Type (2018-2033)
6.3 Americas Organoid Biobank Market Size by Application
6.3.1 Americas Organoid Biobank Market Size by Application (2018-2023)
6.3.2 Americas Organoid Biobank Market Size by Application (2024-2033)
6.3.3 Americas Organoid Biobank Market Share by Application (2018-2033)
6.4 Americas Organoid Biobank Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Organoid Biobank Market Size YoY Growth 2018-2033
7.2 EMEA Organoid Biobank Market Size by Type
7.2.1 EMEA Organoid Biobank Market Size by Type (2018-2023)
7.2.2 EMEA Organoid Biobank Market Size by Type (2024-2033)
7.2.3 EMEA Organoid Biobank Market Share by Type (2018-2033)
7.3 EMEA Organoid Biobank Market Size by Application
7.3.1 EMEA Organoid Biobank Market Size by Application (2018-2023)
7.3.2 EMEA Organoid Biobank Market Size by Application (2024-2033)
7.3.3 EMEA Organoid Biobank Market Share by Application (2018-2033)
7.4 EMEA Organoid Biobank Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Organoid Biobank Market Size YoY Growth 2018-2033
8.2 China Organoid Biobank Market Size by Type
8.2.1 China Organoid Biobank Market Size by Type (2018-2023)
8.2.2 China Organoid Biobank Market Size by Type (2024-2033)
8.2.3 China Organoid Biobank Market Share by Type (2018-2033)
8.3 China Organoid Biobank Market Size by Application
8.3.1 China Organoid Biobank Market Size by Application (2018-2023)
8.3.2 China Organoid Biobank Market Size by Application (2024-2033)
8.3.3 China Organoid Biobank Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Organoid Biobank Market Size YoY Growth 2018-2033
9.2 APAC Organoid Biobank Market Size by Type
9.2.1 APAC Organoid Biobank Market Size by Type (2018-2023)
9.2.2 APAC Organoid Biobank Market Size by Type (2024-2033)
9.2.3 APAC Organoid Biobank Market Share by Type (2018-2033)
9.3 APAC Organoid Biobank Market Size by Application
9.3.1 APAC Organoid Biobank Market Size by Application (2018-2023)
9.3.2 APAC Organoid Biobank Market Size by Application (2024-2033)
9.3.3 APAC Organoid Biobank Market Share by Application (2018-2033)
9.4 APAC Organoid Biobank Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 FRANKFURT CANCER INSTITUTE
10.1.1 FRANKFURT CANCER INSTITUTE Company Details
10.1.2 FRANKFURT CANCER INSTITUTE Business Overview
10.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Introduction
10.1.4 FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2018-2023)
10.1.5 FRANKFURT CANCER INSTITUTE Recent Development
10.2 Merck
10.2.1 Merck Company Details
10.2.2 Merck Business Overview
10.2.3 Merck Organoid Biobank Introduction
10.2.4 Merck Revenue in Organoid Biobank Business (2018-2023)
10.2.5 Merck Recent Development
10.3 Crown Bioscience
10.3.1 Crown Bioscience Company Details
10.3.2 Crown Bioscience Business Overview
10.3.3 Crown Bioscience Organoid Biobank Introduction
10.3.4 Crown Bioscience Revenue in Organoid Biobank Business (2018-2023)
10.3.5 Crown Bioscience Recent Development
10.4 HUB Organoids
10.4.1 HUB Organoids Company Details
10.4.2 HUB Organoids Business Overview
10.4.3 HUB Organoids Organoid Biobank Introduction
10.4.4 HUB Organoids Revenue in Organoid Biobank Business (2018-2023)
10.4.5 HUB Organoids Recent Development
10.5 Cancer Research UK Convergence Science Centre
10.5.1 Cancer Research UK Convergence Science Centre Company Details
10.5.2 Cancer Research UK Convergence Science Centre Business Overview
10.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Introduction
10.5.4 Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2018-2023)
10.5.5 Cancer Research UK Convergence Science Centre Recent Development
10.6 Thermo Fisher Scientific
10.6.1 Thermo Fisher Scientific Company Details
10.6.2 Thermo Fisher Scientific Business Overview
10.6.3 Thermo Fisher Scientific Organoid Biobank Introduction
10.6.4 Thermo Fisher Scientific Revenue in Organoid Biobank Business (2018-2023)
10.6.5 Thermo Fisher Scientific Recent Development
10.7 Corning
10.7.1 Corning Company Details
10.7.2 Corning Business Overview
10.7.3 Corning Organoid Biobank Introduction
10.7.4 Corning Revenue in Organoid Biobank Business (2018-2023)
10.7.5 Corning Recent Development
10.8 STEMCELL Technologies
10.8.1 STEMCELL Technologies Company Details
10.8.2 STEMCELL Technologies Business Overview
10.8.3 STEMCELL Technologies Organoid Biobank Introduction
10.8.4 STEMCELL Technologies Revenue in Organoid Biobank Business (2018-2023)
10.8.5 STEMCELL Technologies Recent Development
10.9 Lonza
10.9.1 Lonza Company Details
10.9.2 Lonza Business Overview
10.9.3 Lonza Organoid Biobank Introduction
10.9.4 Lonza Revenue in Organoid Biobank Business (2018-2023)
10.9.5 Lonza Recent Development
10.10 Prellis Biologics
10.10.1 Prellis Biologics Company Details
10.10.2 Prellis Biologics Business Overview
10.10.3 Prellis Biologics Organoid Biobank Introduction
10.10.4 Prellis Biologics Revenue in Organoid Biobank Business (2018-2023)
10.10.5 Prellis Biologics Recent Development
10.11 Amsbio
10.11.1 Amsbio Company Details
10.11.2 Amsbio Business Overview
10.11.3 Amsbio Organoid Biobank Introduction
10.11.4 Amsbio Revenue in Organoid Biobank Business (2018-2023)
10.11.5 Amsbio Recent Development
10.12 Cellesce
10.12.1 Cellesce Company Details
10.12.2 Cellesce Business Overview
10.12.3 Cellesce Organoid Biobank Introduction
10.12.4 Cellesce Revenue in Organoid Biobank Business (2018-2023)
10.12.5 Cellesce Recent Development
10.13 DefiniGEN
10.13.1 DefiniGEN Company Details
10.13.2 DefiniGEN Business Overview
10.13.3 DefiniGEN Organoid Biobank Introduction
10.13.4 DefiniGEN Revenue in Organoid Biobank Business (2018-2023)
10.13.5 DefiniGEN Recent Development
10.14 3Dnamics Inc.
10.14.1 3Dnamics Inc. Company Details
10.14.2 3Dnamics Inc. Business Overview
10.14.3 3Dnamics Inc. Organoid Biobank Introduction
10.14.4 3Dnamics Inc. Revenue in Organoid Biobank Business (2018-2023)
10.14.5 3Dnamics Inc. Recent Development
10.15 Organoid Therapeutics
10.15.1 Organoid Therapeutics Company Details
10.15.2 Organoid Therapeutics Business Overview
10.15.3 Organoid Therapeutics Organoid Biobank Introduction
10.15.4 Organoid Therapeutics Revenue in Organoid Biobank Business (2018-2023)
10.15.5 Organoid Therapeutics Recent Development
10.16 InSphero
10.16.1 InSphero Company Details
10.16.2 InSphero Business Overview
10.16.3 InSphero Organoid Biobank Introduction
10.16.4 InSphero Revenue in Organoid Biobank Business (2018-2023)
10.16.5 InSphero Recent Development
10.17 AIVITA Biomedical
10.17.1 AIVITA Biomedical Company Details
10.17.2 AIVITA Biomedical Business Overview
10.17.3 AIVITA Biomedical Organoid Biobank Introduction
10.17.4 AIVITA Biomedical Revenue in Organoid Biobank Business (2018-2023)
10.17.5 AIVITA Biomedical Recent Development
10.18 JangoBio
10.18.1 JangoBio Company Details
10.18.2 JangoBio Business Overview
10.18.3 JangoBio Organoid Biobank Introduction
10.18.4 JangoBio Revenue in Organoid Biobank Business (2018-2023)
10.18.5 JangoBio Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Organoid Biobank Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Organoid Biobank Market Trends
Table 3. Organoid Biobank Market Drivers
Table 4. Organoid Biobank Market Challenges
Table 5. Organoid Biobank Market Restraints
Table 6. Global Organoid Biobank Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Organoid Biobank Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Organoid Biobank Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Organoid Biobank Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Organoid Biobank, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Organoid Biobank Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Organoid Biobank Revenue Share by Player, 2018-2023
Table 13. Global Organoid Biobank Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Organoid Biobank by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2022)
Table 15. Global Key Players of Organoid Biobank, Headquarters and Area Served
Table 16. Global Key Players of Organoid Biobank, Product and Application
Table 17. Global Key Players of Organoid Biobank, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Organoid Biobank in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Organoid Biobank Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Organoid Biobank Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Organoid Biobank Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Organoid Biobank Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Organoid Biobank Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Organoid Biobank Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Organoid Biobank Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Organoid Biobank Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Organoid Biobank Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Organoid Biobank Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Organoid Biobank Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Organoid Biobank Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Organoid Biobank Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Organoid Biobank Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Organoid Biobank Market Size by Region (2024-2033) & (US$ Million)
Table 51. FRANKFURT CANCER INSTITUTE Company Details
Table 52. FRANKFURT CANCER INSTITUTE Business Overview
Table 53. FRANKFURT CANCER INSTITUTE Organoid Biobank Product
Table 54. FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 55. FRANKFURT CANCER INSTITUTE Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck Organoid Biobank Product
Table 59. Merck Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Crown Bioscience Company Details
Table 62. Crown Bioscience Business Overview
Table 63. Crown Bioscience Organoid Biobank Product
Table 64. Crown Bioscience Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 65. Crown Bioscience Recent Development
Table 66. HUB Organoids Company Details
Table 67. HUB Organoids Business Overview
Table 68. HUB Organoids Organoid Biobank Product
Table 69. HUB Organoids Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 70. HUB Organoids Recent Development
Table 71. Cancer Research UK Convergence Science Centre Company Details
Table 72. Cancer Research UK Convergence Science Centre Business Overview
Table 73. Cancer Research UK Convergence Science Centre Organoid Biobank Product
Table 74. Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 75. Cancer Research UK Convergence Science Centre Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Organoid Biobank Product
Table 79. Thermo Fisher Scientific Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Corning Company Details
Table 82. Corning Business Overview
Table 83. Corning Organoid Biobank Product
Table 84. Corning Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 85. Corning Recent Development
Table 86. STEMCELL Technologies Company Details
Table 87. STEMCELL Technologies Business Overview
Table 88. STEMCELL Technologies Organoid Biobank Product
Table 89. STEMCELL Technologies Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 90. STEMCELL Technologies Recent Development
Table 91. Lonza Company Details
Table 92. Lonza Business Overview
Table 93. Lonza Organoid Biobank Product
Table 94. Lonza Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 95. Lonza Recent Development
Table 96. Prellis Biologics Company Details
Table 97. Prellis Biologics Business Overview
Table 98. Prellis Biologics Organoid Biobank Product
Table 99. Prellis Biologics Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 100. Prellis Biologics Recent Development
Table 101. Amsbio Company Details
Table 102. Amsbio Business Overview
Table 103. Amsbio Organoid Biobank Product
Table 104. Amsbio Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 105. Amsbio Recent Development
Table 106. Cellesce Company Details
Table 107. Cellesce Business Overview
Table 108. Cellesce Organoid Biobank Product
Table 109. Cellesce Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 110. Cellesce Recent Development
Table 111. DefiniGEN Company Details
Table 112. DefiniGEN Business Overview
Table 113. DefiniGEN Organoid Biobank Product
Table 114. DefiniGEN Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 115. DefiniGEN Recent Development
Table 116. 3Dnamics Inc. Company Details
Table 117. 3Dnamics Inc. Business Overview
Table 118. 3Dnamics Inc. Organoid Biobank Product
Table 119. 3Dnamics Inc. Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 120. 3Dnamics Inc. Recent Development
Table 121. Organoid Therapeutics Company Details
Table 122. Organoid Therapeutics Business Overview
Table 123. Organoid Therapeutics Organoid Biobank Product
Table 124. Organoid Therapeutics Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 125. Organoid Therapeutics Recent Development
Table 126. InSphero Company Details
Table 127. InSphero Business Overview
Table 128. InSphero Organoid Biobank Product
Table 129. InSphero Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 130. InSphero Recent Development
Table 131. AIVITA Biomedical Company Details
Table 132. AIVITA Biomedical Business Overview
Table 133. AIVITA Biomedical Organoid Biobank Product
Table 134. AIVITA Biomedical Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 135. AIVITA Biomedical Recent Development
Table 136. JangoBio Company Details
Table 137. JangoBio Business Overview
Table 138. JangoBio Organoid Biobank Product
Table 139. JangoBio Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 140. JangoBio Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Organoid Biobank Product Picture
Figure 2. Global Organoid Biobank Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Organoid Biobank Market Size 2018-2033 (US$ Million)
Figure 4. United States Organoid Biobank Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Organoid Biobank Market Size 2018-2033 (US$ Million)
Figure 6. United States Organoid Biobank Market Share in Global 2018-2033
Figure 7. Organoid Biobank Report Years Considered
Figure 8. Product Picture of Tissue Derived Organoids
Figure 9. Product Picture of Pluripotent Stem Cell-derived Organoids
Figure 10. Global Organoid Biobank Market Share by Type in 2022 & 2033
Figure 11. Global Organoid Biobank Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Organoid Biobank Market Share by Type (2018-2033)
Figure 13. United States Organoid Biobank Market Share by Type in 2022 & 2033
Figure 14. United States Organoid Biobank Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Organoid Biobank Market Share by Type (2018-2033)
Figure 16. Product Picture of Biopharmaceutical Companies
Figure 17. Product Picture of Contract Research Organizations
Figure 18. Product Picture of Academics and Research Institutes
Figure 19. Global Organoid Biobank Market Share by Application in 2022 & 2033
Figure 20. Global Organoid Biobank Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Organoid Biobank Market Share by Application (2018-2033)
Figure 22. United States Organoid Biobank Market Share by Application in 2022 & 2033
Figure 23. United States Organoid Biobank Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Organoid Biobank Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Organoid Biobank in the World: Market Share by Organoid Biobank Revenue in 2022
Figure 26. Global Organoid Biobank Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Organoid Biobank Market Share by Region (2018-2033)
Figure 28. Americas Organoid Biobank Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Organoid Biobank Market Share by Type (2018-2033)
Figure 30. Americas Organoid Biobank Market Share by Application (2018-2033)
Figure 31. United States Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Organoid Biobank Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Organoid Biobank Market Share by Type (2018-2033)
Figure 37. EMEA Organoid Biobank Market Share by Application (2018-2033)
Figure 38. Europe Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Organoid Biobank Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Organoid Biobank Market Share by Type (2018-2033)
Figure 43. China Organoid Biobank Market Share by Application (2018-2033)
Figure 44. APAC Organoid Biobank Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Organoid Biobank Market Share by Type (2018-2033)
Figure 46. APAC Organoid Biobank Market Share by Application (2018-2033)
Figure 47. Japan Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Organoid Biobank Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. FRANKFURT CANCER INSTITUTE Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 54. Crown Bioscience Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 55. HUB Organoids Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 56. Cancer Research UK Convergence Science Centre Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 58. Corning Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 59. STEMCELL Technologies Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 60. Lonza Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 61. Prellis Biologics Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 62. Amsbio Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 63. Cellesce Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 64. DefiniGEN Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 65. 3Dnamics Inc. Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 66. Organoid Therapeutics Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 67. InSphero Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 68. AIVITA Biomedical Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 69. JangoBio Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed